$AOLS climber. $0.51 called 9/21/13

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
$AOLS climber. $0.51
called 9/21/13 $0.275

logo-header.png
Website

10-Q 5/15/14
1642481658_otc.jpeg

100% Buy
850318709_barchart_logo1.jpg


Shares Outstanding: 134.55M
Float: 33.38M



Tuesday, July 1, 2014

Aeolus Announces Additional Data Demonstrating Efficacy of AEOL 10150 as a Medical Countermeasure Against Exposure to Nerve Agents, Sulfur Mustard Gas and Nitrogen Mustard GasMarketwired( (Tue, Jul 1)

Wednesday, June 18, 2014

Aeolus Announces Publication of Data Demonstrating Efficacy of AEOL 10150 in Animal CEES Model of Mustard Gas Skin ExposureMarketwired( (Wed, Jun 18)

Monday, June 2, 2014

Aeolus Pharmateucticals to Present at LD Micro Invitational ConferenceMarketwired( (Mon, Jun 2)

Thursday, May 15, 2014

Aeolus Announces Second Quarter Fiscal Year 2014 Financial Results and Achievements in Lung-ARS Development ProgramMarketwired( (Thu, May 15)

Friday, February 14, 2014

Aeolus Announces First Quarter Fiscal Year 2014 Financial ResultsMarketwired( (Fri, Feb 14)

Thursday, February 13, 2014

Aeolus Announces Process Improvements and Positive 18 Month Stability Results for AEOL 10150 in New FormulationMarketwired( (Thu, Feb 13)

Monday, February 10, 2014

Aeolus Announces Publication of Data Demonstrating Efficacy of AEOL 10150 in Animal Model of Lung Radiation Exposure; Models Developed for Pivotal Efficacy StudiesMarketwired( (Mon, Feb 10)

Thursday, January 23, 2014

Aeolus Receives Orphan Drug Designation for AEOL 10150 From U.S. FDAMarketwired( (Thu, Jan 23)

Monday, December 23, 2013

Aeolus Announces Fiscal Year 2013 Financial ResultsMarketwired( (Mon, Dec 23)

Thursday, December 5, 2013

Aeolus Files Application for New Patent on AEOL 10150Marketwired( (Thu, Dec 5)

Tuesday, October 29, 2013

Aeolus' AEOl 10150 Significantly Improves Survival and Protects Lungs in Mice Exposed to Lethal RadiationMarketwired( (Tue, Oct 29)

Tuesday, September 17, 2013

BARDA Exercises $6.0MM in Additional Contract Funding for Development of AEOL-10150 as Treatment for Acute Radiation SyndromeMarketwired( (Tue, Sep 17)

Wednesday, September 11, 2013

Aeolus' AEOL 10150 Subject of $4.3 Million US Government Award for Protection Against Nerve Agents; Data Shows Drug Significantly Improves Survival in Animals Following Exposure to Pilocarpine, a Nerve Agent


Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fault Codes vs. Diagnosis: What's the Real Fix?

Updated Category News Views 8

When a Blink Isn’t the Whole Story Ever sat in your car, watched that check engine light flicker on, and felt your heart drop? Yeah, we've all been there. But here’s the kicker: just ‘cause that little demon’s glowing doesn’t mean your mechanic’s got all the answers. That’s where this HelloNation article steps in, trying to shed some light on the difference...

Continue Reading
Altitude+ and ViewLift Celebrate Record Fan Engagement

Updated Category News Views 38

Fresh Off the Bench: Altitude+ Rises Picture this: you're cruising through October, watching the leaves fall and the puck drop, and here come Altitude+ and ViewLift boasting some record numbers. This ain't your everyday puff piece — they've got concrete results to back it up. Altitude+, charging into the 2026–27 NHL and NBA seasons, isn't just surviving; they're...

Continue Reading
Venezuelan Crude Hits Texas: NABEP's Bold Move

Updated Category News Views 0

Venezuelan Crude Docking in Texas Signals New Energy Dynamics Batten down the hatches, 'cause NABEP's Venezuelan crude has made a splashy arrival in Texas. We're talking 1 million barrels, folks, the first of its kind under a fresh U.S. deal. This ain't your grandpa's oil shipment from the Middle East that takes forever to get here—nope, this crude made a pit stop in...

Continue Reading
Heart Attack vs. Cardiac Arrest: Know the Differences

Updated Category News Views 0

Spotting the Crisis: Heart Attack or Cardiac Arrest? When your heart’s in trouble, knowing whether it’s a heart attack or cardiac arrest isn’t just some medical trivia—it could save a life. According to healthcare whiz Justin Doss from Beaumont, Texas, this difference can be the thin line between life and a dire outcome. What's the Deal with These Heart Events?...

Continue Reading
Lincoln Educational Faces Class Action for Stock Drop

Updated Category News Views 68

What's Gripping Lincoln Educational Services? You ever feel like you've stepped into a financial thriller with these education stocks? Well, Lincoln Educational Services (NASDAQ:LINC) is at the heart of one, facing the heat of a class action lawsuit filed by Bleichmar Fonti & Auld LLP. It's all about securities fraud—a dreaded term that no investor wants to hear. The...

Continue Reading
Yuchai Eyes African Market Expansion with Strategic Visits

Updated Category News Views 65

Yuchai's Bold Move into Africa There's something gutsy about a company that doesn't just sit on its achievements but heads out into new territories. China Yuchai International (NYSE: CYD), a big player in powertrain solutions, recently embarked on a strategic tour across the African continent, a move that could well shape their future market playbook. East Africa:...

Continue Reading
Americans' Faith in Democracy Hits New Lows

Updated Category News Views 36

Polarization Beyond Politics: A National Reckoning When you catch wind of a report like this one, it's enough to make you feel like the fabric of democracy is unraveling right before our eyes. We're staring at a national identity crisis, folks, and it's got nothing to do with whether you're waving a red or blue flag. This ain't about party lines; it's about a bigger,...

Continue Reading
Franklin Financial Q3: 59% Net Income Surge Amid Growth

Updated Category News Views 80

Soaring Net Income and Impressive Growth Franklin Financial Services Corporation (NASDAQ: FRAF) seems to be on a roll this year, painting a vivid picture of growth as they close out the third quarter of 2026. With a strong surge in net income—59.4% up from Q3 2025—this leadership in earnings is no fluke. Net Income and Earnings per Share Let's break it down: the...

Continue Reading
Alpheus Explores LDH Kinetics as Glioblastoma Biomarker

Updated Category News Views 40

Cracking Glioblastoma's Tough Shell Some days, you're slogging through numbers that don't add up, and other times, you stumble upon findings that just might change the game. Alpheus Medical, diving headfirst into the murky waters of glioblastoma, dropped some intriguing data at the ESMO Congress 2026. This isn't your usual round of clinical discoveries, folks. What...

Continue Reading
Post University Expands with New Tech and Health Degrees

Updated Category News Views 56

If you're looking to invest in an education with promising payoffs, you might look into what's cooking over at Post University. They've just dropped a bombshell of new programs sure to get some attention from tech heads and health nuts alike, and I can't help but think there's potential brewing here. New Academic Paths Emerge Post University isn't resting on its...

Continue Reading

Top 5 Most Recently Viewed Articles

T1D Fund's Major Capital Raise for Revolutionary Diabetes Solutions

Updated Category News Views 181

Launch of a Transformative Capital Raise by the T1D Fund The T1D Fund has embarked on an exciting new fundraising initiative designed to supercharge investment in groundbreaking solutions for type 1 diabetes (T1D). This fundraising campaign is tailored to stimulate larger, more substantial investments in innovative T1D programs, thanks to the Fund's renowned track record...

Continue Reading
NEST Center's Exciting Renovation Plans Unveiled for Tenants

Updated Category News Views 217

Major Renovation Kickoff at the Northeast Science & Technology Center The Northeast Science & Technology (NEST) Center is launching an ambitious renovation project, aimed at enhancing over 75,000 square feet of shared amenities designed to foster a vibrant ecosystem of research and innovation for both current and future tenants. Innovative Vision for the NEST Center...

Continue Reading
Understanding Tryg's Share Buyback Programme Dynamics

Updated Category News Views 198

Detailed Insights on Tryg's Share Buyback Programme In a strategic move, Tryg A/S has initiated a robust share buyback programme aimed at enhancing shareholder value. This initiative, valued at up to DKK 2.0 billion, signifies Tryg's commitment to boosting the long-term interests of its shareholders. Understanding the Share Buyback Programme The share buyback programme,...

Continue Reading
ST Imaging's ViewScan Earns 11th Platinum Library Award

Updated Category News Views 122

ST Imaging's ViewScan Reigns Supreme at Modern Library Awards In a remarkable achievement for innovation in library technology, ST Imaging's ViewScan 4 has earned the prestigious Platinum Modern Library Award for the eleventh consecutive year. This award, given by LibraryWorks, celebrates excellence in products designed specifically for library environments, and ST...

Continue Reading
Gilead Sciences Insider Moves Spark Investor Interest

Updated Category News Views 163

Insider Activity at Gilead Sciences: Key Updates Recently, a significant transaction was reported by Jeffrey Bluestone, a Board Member at Gilead Sciences (NASDAQ: GILD). In a filing with the SEC, it was revealed that Bluestone exercised stock options for a total of 5,000 shares. This transaction was valued at $296,250, drawing important attention from investors and market...

Continue Reading